Patents by Inventor Junxia QIU

Junxia QIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinolyl-substituted carboxylic acid compound or pharmaceutically acceptable salt thereof, pharmaceutical composition of the same, and use of the same
    Patent number: 10723701
    Abstract: The present application provides a quinolyl-substituted carboxylic acid compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, as well as a method for preparing the compound, a use of the compound, and a formulation containing the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof. This type of compounds are inhibitors for AXL and/or VEGFR2 protein kinase, and can be used to treat diseases caused by abnormality of the two protein kinases, such as, tumor, etc.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: July 28, 2020
    Assignee: BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
    Inventors: Zhiqiang Zhang, Xijuan Wang, Xuehui Zhang, Junxia Qiu, Jiehe Yang, Xiaokai Zhang, Peng Yao
  • QUINOLYL-SUBSTITUTED CARBOXYLIC ACID COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION OF THE SAME, AND USE OF THE SAME
    Publication number: 20190256470
    Abstract: The present application provides a quinolyl-substituted carboxylic acid compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, as well as a method for preparing the compound, a use of the compound, and a formulation containing the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof. This type of compounds are inhibitors for AXL and/or VEGFR2 protein kinase, and can be used to treat diseases caused by abnormality of the two protein kinases, such as, tumor, etc.
    Type: Application
    Filed: September 29, 2017
    Publication date: August 22, 2019
    Applicant: BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
    Inventors: Zhiqiang ZHANG, Xijuan WANG, Xuehui ZHANG, Junxia QIU, Jiehe YANG, Xiaokai ZHANG, Peng YAO